Clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative review

Background and objectives: Oral anticoagulants prevent thromboembolic events but expose patients to a significant risk of bleeding due to the treatment itself, after trauma, or during surgery. Any physician working in the emergency department or involved in the perioperative care of a patient should...

Full description

Bibliographic Details
Main Authors: Carlos Galhardo, Jr., Luiz Henrique Ide Yamauchi, Hugo Dantas, João Carlos de Campos Guerra
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Brazilian Journal of Anesthesiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0104001421001378
id doaj-9f511cc4c77948a6b81f4b41915fdb23
record_format Article
spelling doaj-9f511cc4c77948a6b81f4b41915fdb232021-07-05T04:13:19ZengElsevierBrazilian Journal of Anesthesiology0104-00142021-07-01714429442Clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative reviewCarlos Galhardo, Jr.0Luiz Henrique Ide Yamauchi1Hugo Dantas2João Carlos de Campos Guerra3Hospital São Lucas Copacabana, Departamento de Anestesia, Rio de Janeiro, RJ, Brazil; Instituto Nacional de Cardiologia, Rio de Janeiro, RJ, Brazil; Corresponding author.Centro de Pesquisas Oncológicas (CEPON), Departamento de Anestesia, Florianópolis, SC, BrazilClínica de Anestesiologia, Departamento de Anestesia, Salvador, BA, BrazilHospital Israelita Albert Einstein, Centro de Oncologia e Hematologia, Setor de Hematologia e Coagulação, Departamento de Patologia Clínica, São Paulo, SP, BrazilBackground and objectives: Oral anticoagulants prevent thromboembolic events but expose patients to a significant risk of bleeding due to the treatment itself, after trauma, or during surgery. Any physician working in the emergency department or involved in the perioperative care of a patient should be aware of the best reversal approach according to the type of drug and the patient’s clinical condition. This paper presents a concise review and proposes clinical protocols for the reversal of oral anticoagulants in emergency settings, such as bleeding or surgery. Contents: The authors searched for relevant studies in PubMed, LILACS, and the Cochrane Library database and identified 82 articles published up to September 2020 to generate a review and algorithms as clinical protocols for practical use. Hemodynamic status and the implementation of general supportive measures should be the first approach under emergency conditions. The drug type, dose, time of last intake, and laboratory evaluations of anticoagulant activity and renal function provide an estimation of drug clearance and should be taken into consideration. The reversal agents for vitamin K antagonists are 4-factor prothrombin complex concentrate and vitamin K, followed by fresh frozen plasma as a second-line treatment. Direct oral anticoagulants have specific reversal agents, such as andexanet alfa and idarucizumab, but are not widely available. Another possibility in this situation, but with less evidence, is prothrombin complex concentrates. Conclusion: The present algorithms propose a tool to help healthcare providers in the best decision making for patients under emergency conditions.http://www.sciencedirect.com/science/article/pii/S0104001421001378Reversal of oral anticoagulantsWarfarinNon-vitamin K antagonistsDirect oral anticoagulantsProthrombin complex concentratesIdarucizumab
collection DOAJ
language English
format Article
sources DOAJ
author Carlos Galhardo, Jr.
Luiz Henrique Ide Yamauchi
Hugo Dantas
João Carlos de Campos Guerra
spellingShingle Carlos Galhardo, Jr.
Luiz Henrique Ide Yamauchi
Hugo Dantas
João Carlos de Campos Guerra
Clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative review
Brazilian Journal of Anesthesiology
Reversal of oral anticoagulants
Warfarin
Non-vitamin K antagonists
Direct oral anticoagulants
Prothrombin complex concentrates
Idarucizumab
author_facet Carlos Galhardo, Jr.
Luiz Henrique Ide Yamauchi
Hugo Dantas
João Carlos de Campos Guerra
author_sort Carlos Galhardo, Jr.
title Clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative review
title_short Clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative review
title_full Clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative review
title_fullStr Clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative review
title_full_unstemmed Clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative review
title_sort clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative review
publisher Elsevier
series Brazilian Journal of Anesthesiology
issn 0104-0014
publishDate 2021-07-01
description Background and objectives: Oral anticoagulants prevent thromboembolic events but expose patients to a significant risk of bleeding due to the treatment itself, after trauma, or during surgery. Any physician working in the emergency department or involved in the perioperative care of a patient should be aware of the best reversal approach according to the type of drug and the patient’s clinical condition. This paper presents a concise review and proposes clinical protocols for the reversal of oral anticoagulants in emergency settings, such as bleeding or surgery. Contents: The authors searched for relevant studies in PubMed, LILACS, and the Cochrane Library database and identified 82 articles published up to September 2020 to generate a review and algorithms as clinical protocols for practical use. Hemodynamic status and the implementation of general supportive measures should be the first approach under emergency conditions. The drug type, dose, time of last intake, and laboratory evaluations of anticoagulant activity and renal function provide an estimation of drug clearance and should be taken into consideration. The reversal agents for vitamin K antagonists are 4-factor prothrombin complex concentrate and vitamin K, followed by fresh frozen plasma as a second-line treatment. Direct oral anticoagulants have specific reversal agents, such as andexanet alfa and idarucizumab, but are not widely available. Another possibility in this situation, but with less evidence, is prothrombin complex concentrates. Conclusion: The present algorithms propose a tool to help healthcare providers in the best decision making for patients under emergency conditions.
topic Reversal of oral anticoagulants
Warfarin
Non-vitamin K antagonists
Direct oral anticoagulants
Prothrombin complex concentrates
Idarucizumab
url http://www.sciencedirect.com/science/article/pii/S0104001421001378
work_keys_str_mv AT carlosgalhardojr clinicalprotocolsfororalanticoagulantreversalduringhighriskofbleedingforemergencysurgicalandnonsurgicalsettingsanarrativereview
AT luizhenriqueideyamauchi clinicalprotocolsfororalanticoagulantreversalduringhighriskofbleedingforemergencysurgicalandnonsurgicalsettingsanarrativereview
AT hugodantas clinicalprotocolsfororalanticoagulantreversalduringhighriskofbleedingforemergencysurgicalandnonsurgicalsettingsanarrativereview
AT joaocarlosdecamposguerra clinicalprotocolsfororalanticoagulantreversalduringhighriskofbleedingforemergencysurgicalandnonsurgicalsettingsanarrativereview
_version_ 1721319084528762880